In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Actelion sells CF143.75mm in convertible debt

Executive Summary

Actelion privately sold CHF143.75mm ($109.15mm; including the overallotment) of zero coupon convertible senior debt due 2008. The bonds have a yield-to-maturity of 4.75% and convert into registered common shares at an initial 35% premium, based on the day prior to the close of the transaction.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies